Skip to main content
Teva Pharmaceutical Industries Limited (TLV:TEVA)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
5,950.00
+2.00 (0.03%)
Jun 19, 2025, 10:45 AM IDT

TLV:TEVA Revenue

Teva Pharmaceutical Industries had revenue of $3.89B USD in the quarter ending March 31, 2025, with 1.89% growth. This brings the company's revenue in the last twelve months to $16.62B, up 3.82% year-over-year. In the year 2024, Teva Pharmaceutical Industries had annual revenue of $16.54B with 4.40% growth.

Revenue (ttm)
$16.62B
Revenue Growth
+3.82%
P/S Ratio
1.10
Revenue / Employee
$465.62K
Employees
35,686
Market Cap
67.91B ILS

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202416.54B698.00M4.40%
Dec 31, 202315.85B921.00M6.17%
Dec 31, 202214.93B-953.00M-6.00%
Dec 31, 202115.88B-781.00M-4.69%
Dec 31, 202016.66B-228.00M-1.35%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Danel (Adir Yeoshua) 2.81B
Kamada 622.70M
Bait Bakfar 104.50M
BrainsWay 161.81M
Novolog (Pharm-Up 1966) 2.07B
SofWave Medical 235.09M
Ilex Medical 922.08M
InterCure 238.85M
Revenue Rankings

Teva Pharmaceutical Industries News

More News